患者偏好与前列腺癌治疗决策:全州泌尿外科质量改进协作组结果
研究纳入密歇根泌尿外科质量改进协作组注册的2018-2020年局限性前列腺癌患者509例,分析完成个人患者档案-前列腺决策辅助工具后,未来膀胱、肠道和性功能问题对治疗决策的影响程度与治疗选择的关系。在非 reassuring 确认检测结果者中,重视影响因素者选择主动监测的比例更高。结论提示决策辅助工具引出的功能担忧可能解释偏离传统临床推荐的治疗选择。
要点
- 完成决策辅助工具的509例局限性前列腺癌患者中,88%有利风险者和49%不利风险者的治疗决策与影响因素一致。
- 按风险分层后,有利风险组主动监测比例分别为78%和67%,不利风险组分别为17%和9%。
核心结论
- 决策辅助工具引出的患者对未来膀胱、肠道和性功能问题的担忧,可能有助于解释偏离传统临床推荐的治疗选择。
研究设计与样本
- 基于密歇根泌尿外科质量改进协作组注册数据库的回顾性分析,纳入2018-2020年诊断为局限性前列腺癌并完成个人患者档案-前列腺决策辅助工具的男性509例。
主要发现
- 治疗决策与影响因素一致的比例在有利风险患者中为88%,在不利风险患者中为49%。
- 按风险分层,有利风险组主动监测比例分别为78%和67%,不利风险组分别为17%和9%。
- 在非 reassuring 确认检测结果者中,影响因素有「很大影响」者选择主动监测的比例高于「无影响」者,但样本量小。
临床怎么用
- 在前列腺癌治疗决策中,可使用决策辅助工具评估患者对未来膀胱、肠道和性功能问题的担忧程度,以理解其治疗偏好。
局限性
- 样本量小,尤其是非 reassuring 确认检测结果亚组。
- 观察性设计,无法推断因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine the relationship between influential factors and treatment decisions among men with newly diagnosed prostate cancer (PCa). METHODS: We identified men in the Michigan Urological Surgery Improvement Collaborative registry diagnosed with localized PCa between 2018-2020 who completed Personal Patient Profile-Prostate. We analyzed the proportion of active surveillance (AS) between men who stated future bladder, bowel, and sexual problems (termed influential factors) had "a lot of influence" on their treatment decisions versus other responses. We also assessed the relationship between influential factors, confirmatory testing results and choice of AS. RESULTS: A total of 509 men completed Personal Patient Profile-Prostate. Treatment decisions aligned with influential factors for 88% of men with favorable risk and 49% with unfavorable risk PCa. A higher proportion of men who identified bladder, bowel and sexual concerns as having "a lot of influence" on their treatment decision chose AS, compared with men with other influential factors, although not statistically significant (44% vs 35%, P = .11). Similar results were also found when men were stratified based on PCa risk groups (favorable risk: 78% vs 67%; unfavorable risk: 17% vs 9%, respectively). Despite a small sample size, a higher proportion of men with non-reassuring confirmatory testing selected AS if influential factors had "a lot of influence" compared to "no influence" on their treatment decisions. CONCLUSION: Men's concerns for future bladder, bowel, and sexual function problems, as elicited by a decision aid, may help explain treatment selection that differs from traditional clinical recommendation.
引用
- Paudel R, Ferrante S, Qi J, et al. Patient Preferences and Treatment Decisions for Prostate Cancer: Results From A Statewide Urological Quality Improvement Collaborative. Urology. 2021. PMID: 33933504. doi:10.1016/j.urology.2021.04.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。